Related Experiment Video
Updated: May 8, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow
Mary F McGuire1, Heiko Enderling, Dorothy I Wallace
1Authors' Affiliations: University of Texas Medical School at Houston, Houston, Texas; Center of Cancer Systems Biology, Steward Research & Specialty Projects Corp., St. Elizabeth's Medical Center, Tufts University School of Medicine; Division of Cell and Molecular Biology, Department of Biology, Boston University, Boston, Massachusetts; Department of Mathematics, Dartmouth College, Hanover, New Hampshire; St. Jude Children's Research Hospital, Memphis, Tennessee; Hospital for Sick Children, Toronto, Ontario, Canada; Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Randwick, NSW, Australia; and Metronomics Global Health Initiative, Marseille, France.
This study presents a workflow template for multidisciplinary cancer therapy, integrating clinicians and scientists. This approach accelerates discovery and validation of new cancer treatments.
Area of Science:
- Oncology
- Systems Biology
- Computational Biology
Background:
- Limited collaboration hinders cancer research progress due to constraints in time, distance, data, and budget.
- Effective integration of diverse expertise is crucial for advancing cancer therapy development.
Purpose of the Study:
- To present a workflow template for multidisciplinary cancer therapy development.
- To demonstrate the template's application in creating a metronomic therapy backbone for neuroblastoma.
- To outline an interdisciplinary collaboration model for systematic investigation and validation of novel cancer therapies.
Main Methods:
- Development of an integrative workflow template involving clinicians, biologists, and quantitative scientists.
- Application of the template to a neuroblastoma metronomic therapy backbone.
- Description of parallel/sequential processes, data sources, computational tools, and iterative development stages.
Main Results:
- The workflow facilitates dialogue between theoreticians and experimentalists, leading to predictive models.
- Calibrated models inform and formalize testable hypotheses, accelerating discovery and validation.
- The process reduces laboratory resources and costs while enhancing therapeutic development.
Conclusions:
- The developed template provides a systematic framework for interdisciplinary collaboration in cancer therapy research.
- This workflow enhances the investigation of mechanistic underpinnings and validation of new therapies.
- The approach aims to expedite the advancement and clinical acceptance of novel cancer treatments.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
